Navigation Links
Leading global Big Pharma companies of 2005

I always look forward to writing this particular article with great anticipation! Why, you say? It is part of an annual ritual that I have followed with eagerness as I grew up in the pharmaceutical industry, initiating in my 10 years at Pfizer (way before Pfizer was the juggernaut it is today). At Pfizer, we were all anxious to see the annual company ranking results ......

Full article >>> an old friend and colleague who was retiring from Pfizer the week that I was there, after 31 years with the company. In fact, he and I started at Pfizer the same year (wow, I was really feeling old).

As I toured Pfizer Brazil's offices, we were reminiscing of the old days when Pfizer's offices in most Latin American countries were usually located 45 minutes to an hour from city centers a......

Full article >>> >N/ARoche* (Swiss + Chugai)$15.7N/A99Wyeth (U.S.)$15.3+10%108Bristol-Myers Squibb$15.3<1%>1111Eli Lilly (U.S.)$14.7+12%1210Abbott Labs (U.S.)$14.0+16%
Full article >>> les from acquisition of Japanese company Chugai but does not include sales from majority-owned position in Genentech
** merger of Yamanouchi and Fujisawa to become Astellas
*** does not include recently-announced acquisition of Schering AG
**** merger in September, 2005 of Daiichi and Sankyo

By the way, as a manner of comparison, let's take a look at the rankings of the pharm......

Full article >>> re within the top 30 companies, Amgen and Genentech, with Amgen close to breaking into the top 10 companies although its growth is slowing down; Genentech continues to move up in the ranks and actually finished the year with a market cap higher than Amgen's - approaching $100 billion
  • The Japanese companies continue to globalize due to the weakness of their own home market and inc......

    Full article >>> 6Novartis$4.518.0%7Roche (includes Chugai)$4.226.8%8Merck$3.817.3%9Eli Lilly$3.020.4%10Amgen$2.319.2%11Schering-Plough$1.925.0%
    Full article >>> >Abbott Labs at about 13% of sales is on the low side while Eli Lilly is aggressively investing (20% of sales); Baxter, at about 17% of sales, is just slightly above the average for the industry.

    Note that, on average, 50% of a Big Pharma's R&D budget is being spent on the development of in-licensed drugs (from smaller companies), with some companies spend......

    Full article >>> altimore, Chicago, Cleveland, and Denver. Rosen is also a founder and board member of the Illinois Biotechnology Industry Organization. He can be reached at rosenmichaels@aol.com

  • The opinions expressed herein or statements made in the above column are solely those of the author and do not necessarily reflect th......

    Full article >>>
    '"/>

    Source:wistechnology.com By Michael Rosen 05/09/06


    Related biology technology :

    1. Leading cancer institute to install three TomoTherapy systems
    2. The state of global biotech: An Ernst & Young perspective
    3. Doyle announces new energy, global warming policies
    4. Lucigen Corp. enters global licensing agreement
    5. Work-life imbalance - A global problem getting worse
    6. Learning to swim in the global talent pool
    7. Federal and global guidelines on stem cell research offer a level playing field
    8. Wisconsin plant is part of NCRs global RFID initiative
    9. Whither Wisconsin manufacturing in the new global economy?
    10. In the wake of Katrina, more questions than answers about global climate change
    11. Is America prepared to win the global skills race?
    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:2/4/2016)... 2016 - New FDA action date of ... FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast has ... indicated for the treatment of signs and symptoms of dry eye ... potential to be the only product approved in the U.S. in the past decade indicated ...
    (Date:2/4/2016)... ... February 04, 2016 , ... ... Digital Forensics Club, takes place February 5-6 at the University’s student center, ... and activities such as workshops and competitions for ample networking, learning and ...
    (Date:2/4/2016)... Columbia and MENLO PARK, Calif. ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused ... announced that it will present at the 18 th ... February 8, 2016 at 10:00 a.m. EST in ... , DelMar,s president and CEO, will provide an update on ...
    (Date:2/4/2016)... -- Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property development ... property, today provided an update on the Company,s cases ... Texas and announcing that those ... Re-examination ("IPR") proceedings that VTech and Uniden filed ... on only certain claims of two of the patents ...
    Breaking Biology Technology:
    (Date:2/1/2016)... Feb. 1, 2016  Today, the first day of ... plans to develop a first of its kind workplace ... IBM Watson. In the first application of ... IBM ), and Welltok will create a new ... with cognitive analytics, delivered on Welltok,s health optimization platform. ...
    (Date:1/25/2016)...   Unisys Corporation (NYSE: UIS ) today announced ... International Airport, New York City , to help ... to enter the United States using passports ... pilot testing of the system at Dulles last year. The ... during January 2016. --> pilot testing of the ...
    (Date:1/21/2016)... --> ... report "Emotion Detection and Recognition Market by Technology (Bio-Sensors, NLP, ... Voice Recognition and Others), Services, Application Areas, End ... published by MarketsandMarkets, the global Emotion Detection and ... Billion by 2020, at a CAGR of 31.9%, ...
    Breaking Biology News(10 mins):